INVO Bioscience (NASDAQ:INVO) Stock Price Down 3.9% – Should You Sell?

Shares of INVO Bioscience, Inc. (NASDAQ:INVO) fell 3.9% on Wednesday . The company traded as low as $0.78 and last traded at $0.78. 25,997 shares changed hands during trading, a decline of 98% from the average session volume of 1,587,563 shares. The stock had previously closed at $0.81.

INVO Bioscience Stock Performance

The stock’s 50 day moving average is $0.86 and its two-hundred day moving average is $0.83.

Institutional Trading of INVO Bioscience

An institutional investor recently bought a new position in INVO Bioscience stock. CWC Advisors LLC. bought a new position in shares of INVO Bioscience, Inc. (NASDAQ:INVO) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned 2.64% of INVO Bioscience as of its most recent filing with the Securities and Exchange Commission (SEC). 12.02% of the stock is currently owned by institutional investors.

INVO Bioscience Company Profile

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.